Ori Biotech to Present Scientific Data at 2023 Cell & Gene Meeting on the Mesa
LONDON, UK, OCTOBER 9, 2023 – Ori Biotech announces today that Jason C. Foster, Chief Executive Officer, will present, for the first time publicly, scientific data for the Ori platform at the annual Cell & Gene Meeting on the Mesa to be held October 10-12 in Carlsbad, California and livestreamed globally.
Ori Biotech is a London and New Jersey based manufacturing technology company pioneering flexible process discovery with seamless translation and scalable commercialization of cell and gene therapies. Ori has developed a proprietary, full-stack manufacturing platform that closes, automates and standardizes CGT manufacturing allowing therapeutics developers to develop and bring their products to market at commercial scale. The promise of the innovative Ori platform is to fully automate CGT manufacturing to increase throughput, improve quality and decrease costs by combining proprietary hardware, software, data and analytics.
Ori was founded in 2015 by Dr. Farlan Veraitch (UCL) and has brought together a seasoned Board and management team with over 200 years of combined pharmaceutical, CGT and venture building experience, including CEO Jason C. Foster (Indivior), CDOO Kevin Gordon (Tmunity), CTO Stuart Milne (Cytiva), CCO Tom Heathman (Minaris), VP Lee Unroe (Indivior), Chris Mason (AVROBIO), Paul Meister (ThermoFisher) and Annalisa Jenkins (Dimension Therapeutics) alongside expert advisers like Bruce Levine and Robert Preti. For more information, visit http://www.oribiotech.com/.
Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Mesa is a three-day conference featuring more than 120 dedicated company presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and broader regenerative medicine technologies, as well as over 100 panelists and featured speakers.
The following are specific details regarding Ori Biotech’s presentation at the conference:
Event: 2023 Cell & Gene Meeting on the Mesa
Date: October 10, 2023
Time: 12:00 pm PST
Location: Rentschler ATMP Ballroom at the Park Hyatt Aviara Resort, 7100 Aviara Resort Dr., Carlsbad, CA 92011
Complimentary attendance at this event is available for credentialed investors and members of the media only. Investors should contact Savannah Bryant at sbryant@alliancerm.org and interested media should contact Stephen Majors at smajors@alliancerm.org.
Virtual attendance is available, which includes a livestream of Ori Biotech’s presentation and the ability to view all conference sessions on-demand. Please visit https://meetingonthemesa.com for full information, including registration.
About Ori Biotech
Ori is a London- and New Jersey-based manufacturing technology company pioneering flexible process discovery with seamless translation and scalable commercialization of cell and gene therapies. Ori has developed a proprietary, full-stack manufacturing platform that closes, automates and standardizes CGT manufacturing, allowing therapeutics developers to develop and bring their products to market at commercial scale. The promise of the innovative Ori platform is to fully automate CGT manufacturing to increase throughput, improve quality and decrease costs by combining proprietary hardware, software, data and analytics. For more information, visit oribiotech.com.
